SIONNA THERAPEUTICS, INC. (SION) ROE
- 2026-06-30: ROE -36.64%.
- 2026-03-31: ROE -29.69%.
- 2025-12-31: ROE -24.53%.
- 2025-09-30: ROE -21.97%.
Complete source-backed roe history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -36.64% |
| 2026-03-31 | -29.69% |
| 2025-12-31 | -24.53% |
| 2025-09-30 | -21.97% |
| 2025-06-30 | -22.54% |
| 2025-03-31 | -18.85% |
| 2024-12-31 | 37.68% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -24.53% |
| 2024-12-31 | 37.68% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |